Suppr超能文献

通过对MET受体酪氨酸激酶结构域进行深度突变扫描揭示了近膜结构域和激酶N叶中的保守调控基序。

Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain.

作者信息

Estevam Gabriella O, Linossi Edmond M, Macdonald Christian B, Espinoza Carla A, Michaud Jennifer M, Coyote-Maestas Willow, Collisson Eric A, Jura Natalia, Fraser James S

机构信息

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco,United States.

Tetrad Graduate Program, University of California San Francisco, San Francisco, United States.

出版信息

bioRxiv. 2024 May 6:2023.08.03.551866. doi: 10.1101/2023.08.03.551866.

Abstract

MET is a receptor tyrosine kinase (RTK) responsible for initiating signaling pathways involved in development and wound repair. MET activation relies on ligand binding to the extracellular receptor, which prompts dimerization, intracellular phosphorylation, and recruitment of associated signaling proteins. Mutations, which are predominantly observed clinically in the intracellular juxtamembrane and kinase domains, can disrupt typical MET regulatory mechanisms. Understanding how juxtamembrane variants, such as exon 14 skipping (METΔEx14), and rare kinase domain mutations can increase signaling, often leading to cancer, remains a challenge. Here, we perform a parallel deep mutational scan (DMS) of the MET intracellular kinase domain in two fusion protein backgrounds: wild type and METΔEx14. Our comparative approach has revealed a critical hydrophobic interaction between a juxtamembrane segment and the kinase αC-helix, pointing to potential differences in regulatory mechanisms between MET and other RTKs. Additionally, we have uncovered a β5 motif that acts as a structural pivot for the kinase domain in MET and other TAM family of kinases. We also describe a number of previously unknown activating mutations, aiding the effort to annotate driver, passenger, and drug resistance mutations in the MET kinase domain.

摘要

MET是一种受体酪氨酸激酶(RTK),负责启动参与发育和伤口修复的信号通路。MET的激活依赖于配体与细胞外受体的结合,这会促使二聚化、细胞内磷酸化以及相关信号蛋白的募集。临床上主要在细胞内近膜区和激酶结构域观察到的突变,可能会破坏典型的MET调节机制。了解近膜区变体(如14号外显子跳跃,即METΔEx14)和罕见的激酶结构域突变如何增加信号传导并常常导致癌症,仍然是一项挑战。在此,我们在两种融合蛋白背景下对MET细胞内激酶结构域进行了平行深度突变扫描(DMS):野生型和METΔEx14。我们的比较方法揭示了近膜区片段与激酶αC螺旋之间关键的疏水相互作用,这表明MET与其他RTK在调节机制上可能存在差异。此外,我们发现了一个β5基序,它是MET和其他TAM激酶家族中激酶结构域的结构枢纽。我们还描述了一些以前未知的激活突变,有助于对MET激酶结构域中的驱动突变、乘客突变和耐药突变进行注释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/82398d0ad945/nihpp-2023.08.03.551866v3-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验